Article Versions Notes

Ripoll C, Herrero-Foncubierta P, Puente-Muñoz V, Gonzalez-Garcia MC, Miguel D, Resa S, Paredes JM, Ruedas-Rama MJ, Garcia-Fernandez E, Roldan M, et al. Chimeric Drug Design with a Noncharged Carrier for Mitochondrial Delivery. Pharmaceutics. 2021; 13(2):254. https://doi.org/10.3390/pharmaceutics13020254

Ripoll, Consuelo, Pilar Herrero-Foncubierta, Virginia Puente-Muñoz, M. Carmen Gonzalez-Garcia, Delia Miguel, Sandra Resa, Jose M. Paredes, Maria J. Ruedas-Rama, Emilio Garcia-Fernandez, Mar Roldan, and et al. 2021. "Chimeric Drug Design with a Noncharged Carrier for Mitochondrial Delivery" Pharmaceutics 13, no. 2: 254. https://doi.org/10.3390/pharmaceutics13020254

Ripoll, C., Herrero-Foncubierta, P., Puente-Muñoz, V., Gonzalez-Garcia, M. C., Miguel, D., Resa, S., Paredes, J. M., Ruedas-Rama, M. J., Garcia-Fernandez, E., Roldan, M., Rocha, S., De Keersmaecker, H., Hofkens, J., Martin, M., Cuerva, J. M., & Orte, A. (2021). Chimeric Drug Design with a Noncharged Carrier for Mitochondrial Delivery. Pharmaceutics, 13(2), 254. https://doi.org/10.3390/pharmaceutics13020254